Phenytoin clearances in a compliant population: description and application

Area of Science:

• Pharmacokinetics
• Clinical Pharmacology
• Drug Dosing Optimization

Background:

• Phenytoin (PHT) exhibits saturable elimination kinetics, complicating precise therapeutic drug monitoring.
• Accurate PHT dosing is crucial for managing epilepsy and preventing toxicity.

Purpose of the Study:

• To evaluate a novel Population Clearance Method (PCM) for predicting phenytoin dosing requirements.
• To compare the accuracy and bias of PCM against established dosing prediction methods.

Main Methods:

• A simple exponential equation was derived using 177 phenytoin clearance and steady-state concentration pairs from 59 patients.
• PCM predictions were compared with Bayesian, average Vmax, and average Km methods using data from independent patient populations.

Main Results:

• The Bayesian method demonstrated the highest precision and least bias.
• PCM was found to be relatively precise but biased towards underprediction (mean underprediction of 46 mg).
• Average Vmax and Km methods showed mean underpredictions of 21 mg and 11 mg, respectively.

Conclusions:

• PCM provides a straightforward and relatively precise approach for predicting phenytoin doses.
• Clinical application of PCM necessitates rounding calculated doses upward to mitigate underprediction bias.
• While not as unbiased as the Bayesian method, PCM's ease of use makes it a valuable tool for phenytoin dose adjustment.